简氏激酶细胞因子受体复合物的结构揭示了二次激活的基础
Caleb R Glassman1, Naotaka Tsutsumi1,2, Robert A Saxton1,2
1Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA.
概括
我们确定了 Janus 激酶 1 (JAK1) 与细胞因子受体复合的冷电子显微镜结构. 该结构揭示了JAK1中的突变如何通过促进构成性激活来驱动癌症,从而提供新的治疗点.
科学领域:
- 生物化学
- 结构生物学
- 分子瘤学
背景情况:
- 细胞因子通过细胞表面受体二极体激活细胞内亚努斯激酶 (JAKs).
- 在细胞因子信号传递途径中,JAKs至关重要,并且它们的失调与骨髓增殖性瘤有关.
研究的目的:
- 阐明JAK1激活的结构基础,特别是在致癌突变的背景下.
- 提供有关JAKs全激活机制的见解.
主要方法:
- 低温电子显微镜 (低温电子显微镜) 的分辨率为3.6安格斯特罗姆.
- 用细胞因子受体域复合的全长JAK1的结构分析.
- JAK1突变的特征,包括流行的→氨酸 (VF) 突变.
主要成果:
- 该结构显示了JAK1作为一个扩展单元,由伪激酶 (PK) 域包装介导的二分化.
- 致癌性VF突变增强了PK域包装,导致了独立于体的JAK1激活.
- 碳氧终端氨酸激酶域被定位为STAT酸化.
结论:
- 该JAK1结构提供了对瘤激活的分子理解.
- 这些发现支持JAKs的两步化激活模型.
- 该研究确定了针对瘤JAK信号的潜在治疗策略.
相关概念视频
The JAK-STAT Signaling Pathway
9.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.5K
Assembly of Signaling Complexes
6.0K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.0K
Receptor Tyrosine Kinases
14.8K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
14.8K
Interactions Between Signaling Pathways
6.6K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Enzyme-linked Receptors
80.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
80.4K
Amplifying Signals via Enzymatic Cascade
11.3K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
11.3K


